FDA Law Blog

JANUARY 6, 2022

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. S&G Labs has no contractual relationships with the entities that referred clients to S&G Labs. 18 U.S.C. §

Lab Testing 52

Lab Testing Referral Individual Patient-Centered 52

FDA Law Blog

JANUARY 6, 2022

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. S&G Labs has no contractual relationships with the entities that referred clients to S&G Labs. 18 U.S.C. §

Lab Testing 40

Lab Testing Referral Individual Patient-Centered 40

GeriPal

JULY 21, 2022

Eric: For those of you don’t know, Emmy was on our podcast back in 2018 … man, pre-COVID times. Because how that is approached can have lasting effects on relationships, unfortunately. I mean, it seems like it would make a lot of sense for car insurance companies … And there is one. Eric: Yeah. Emmy: Yeah.

Families 102

Families Family IT Diagnosis 102